Sept 6 (Reuters) - Endo International PLC ENDP.O :
* ENDO ANNOUNCES SUBMISSION OF BIOLOGICS LICENSE APPLICATION TO FDA FOR COLLAGENASE CLOSTRIDIUM HISTOLYTICUM (CCH) IN PATIENTS WITH CELLULITE
* SUBMISSION IS BASED ON POSITIVE RESULTS FROM TWO IDENTICAL PHASE 3 RELEASE STUDIES